Similar articles

• The role of pharmacogenetics in treating central nervous system disorders.

  Patnaik M, Renda MJ, Athanasiou MC, Reed CR. Patnaik M, et al. Exp Biol Med (Maywood). 2008 Dec;233(12):1504-9. doi: 10.3181/0806-S-195. Epub 2008 Oct 10. Exp Biol Med (Maywood). 2008. PMID: 18849543
• Preventive practice patterns of Canadian primary care physicians.

  Bass MJ, Elford RW. Bass MJ, et al. Am J Prev Med. 1988;4(4 Suppl):17-23; discussion 24-6. Am J Prev Med. 1988. PMID: 3079139 Review. No abstract available.
• Pharmacogenomic testing in a tertiary care outpatient psychosomatic medicine practice.

  Rundell JR, Staab JP, Shinozaki G, Saad-Pendergrass D, Moore K, McAlpine D, Mrazek D. Rundell JR, et al. Psychosomatics. 2011 Mar-Apr;52(2):141-6. doi: 10.1016/j.psym.2010.12.023. Psychosomatics. 2011. PMID: 21397106
• Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.

  Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ. Power TJ, et al. Pediatrics. 2008 Jan;121(1):e65-72. doi: 10.1542/peds.2007-0383. Pediatrics. 2008. PMID: 18166546
• Pharmacogenetics.

  Bishop JR. Bishop JR. Handb Clin Neurol. 2018;147:59-73. doi: 10.1016/B978-0-444-63233-3.00006-3. Handb Clin Neurol. 2018. PMID: 29325628 Review.